These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15312829)

  • 1. FR167653 reduces obliterative airway disease in rats.
    Farivar AS; Mackinnon-Patterson B; Woolley S; Namkung J; Shimamoto A; Verrier ED; Mulligan MS
    J Heart Lung Transplant; 2004 Aug; 23(8):985-92. PubMed ID: 15312829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly (ADP) ribose synthetase inhibition reduces obliterative airway disease in rat tracheal allografts.
    Farivar AS; Woolley SM; Naidu BV; Fraga CH; Byrne K; Thomas R; Salzman AL; Szabo CS; Mulligan MS
    J Heart Lung Transplant; 2004 Aug; 23(8):993-1002. PubMed ID: 15312830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obliterative airway disease in rat tracheal allografts requires tumor necrosis factor alpha.
    Farivar AS; Mackinnon-Patterson B; McCourtie AS; Namkung J; Ward PA; Mulligan MS
    Exp Mol Pathol; 2005 Jun; 78(3):190-7. PubMed ID: 15924870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibition of p38 mitogen-activated protein kinase with FR167653 attenuates vascular proliferation in monocrotaline-induced pulmonary hypertension in rats.
    Lu J; Shimpo H; Shimamoto A; Chong AJ; Hampton CR; Spring DJ; Yada M; Takao M; Onoda K; Yada I; Pohlman TH; Verrier ED
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):850-9. PubMed ID: 15573069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
    Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
    Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FR167653 Ameliorates expression of proinflammatory mediators in human umbilical venous endothelial cells and human monocytes.
    Schaub M; Harwaldt P; Wilhelm J; Heidt MC; Grebe M; Tillmanns H; Stadlbauer TH
    Transplant Proc; 2009; 41(6):2616-20. PubMed ID: 19715986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of recipient macrophages by gadolinium chloride prevents development of obliterative airway disease in a rat model of heterotopic tracheal transplantation.
    Oyaizu T; Okada Y; Shoji W; Matsumura Y; Shimada K; Sado T; Sato M; Kondo T
    Transplantation; 2003 Oct; 76(8):1214-20. PubMed ID: 14578756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No gender difference in development of obliterative airway disease in rat tracheal allografts.
    Antus B; Fillinger J; Sebe A; Jeney C; Soltesz I; Horvath I
    Exp Mol Pathol; 2006 Dec; 81(3):235-8. PubMed ID: 16859678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FR167653 diminishes infarct size in a murine model of myocardial ischemia-reperfusion injury.
    Yada M; Shimamoto A; Hampton CR; Chong AJ; Takayama H; Rothnie CL; Spring DJ; Shimpo H; Yada I; Pohlman TH; Verrier ED
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):588-94. PubMed ID: 15457160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The macrolide clarithromycin inhibits experimental post-transplant bronchiolitis obliterans.
    Remund K; Rechsteiner T; Guo Z; Rentsch K; Boehler A
    Exp Lung Res; 2009 Dec; 35(10):830-40. PubMed ID: 19995277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.
    Reichenspurner H; Soni V; Nitschke M; Berry GJ; Brazelton T; Shorthouse R; Huang X; Boname J; Girgis R; Raitz BA; Mocarski E; Sandford G; Morris RE
    J Heart Lung Transplant; 1998 May; 17(5):439-51. PubMed ID: 9628562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of airway obliteration by ciprofloxacin in experimental posttransplant bronchiolitis obliterans.
    Remund K; Rechsteiner T; Rentsch K; Vogt P; Russi EW; Boehler A
    Transplantation; 2008 Mar; 85(5):726-31. PubMed ID: 18337667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FR167653 improves renal recovery and decreases inflammation and fibrosis after renal ischemia reperfusion injury.
    Cau J; Favreau F; Zhang K; Febrer G; de la Motte GR; Ricco JB; Goujon JM; Hauet T
    J Vasc Surg; 2009 Mar; 49(3):728-40. PubMed ID: 19268775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial protective effect of FR167653; a novel cytokine inhibitor in ischemic-reperfused rat heart.
    Aleshin A; Sawa Y; Ono M; Funatsu T; Miyagawa S; Matsuda H
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):974-80. PubMed ID: 15519192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
    Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
    Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roflumilast inhibits lipopolysaccharide-induced inflammatory mediators via suppression of nuclear factor-kappaB, p38 mitogen-activated protein kinase, and c-Jun NH2-terminal kinase activation.
    Kwak HJ; Song JS; Heo JY; Yang SD; Nam JY; Cheon HG
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1188-95. PubMed ID: 16126838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cyclosporine A and interleukin-2 in obliterative airway disease in a rat tracheal transplant model.
    Gu Y; Takao M; Kai M; Lu L; Shimamoto A; Onoda K; Shimono T; Tanaka K; Shimpo H; Shiraishi T; Yada I
    Ann Thorac Cardiovasc Surg; 2000 Aug; 6(4):224-31. PubMed ID: 11042477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dual inhibitor of TNF-alpha and IL-1 mitigates liver and kidney dysfunction and improves survival in rat endotoxemia.
    Takeyoshi I; Yoshinari D; Kobayashi M; Kurabayashi M; Morishita Y
    Hepatogastroenterology; 2005; 52(65):1507-10. PubMed ID: 16201107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pirfenidone inhibits obliterative airway disease in mouse tracheal allografts.
    Zhou H; Latham CW; Zander DS; Margolin SB; Visner GA
    J Heart Lung Transplant; 2005 Oct; 24(10):1577-85. PubMed ID: 16210133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparins do not modify obliterative airway disease in rat tracheal allografts.
    Fillinger J; Antus B
    Exp Lung Res; 2010 Dec; 36(10):625-31. PubMed ID: 20860540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.